We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-1.1%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$2.05B
AUM Growth
+$4.1M
Cap. Flow
+$55.1M
Cap. Flow %
2.69%
Top 10 Hldgs %
6.78%
Holding
2,312
New
444
Increased
666
Reduced
682
Closed
516

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.7M
2
MA icon
Mastercard
MA
+$9.24M
3
DIS icon
Walt Disney
DIS
+$8.67M
4
BMY icon
Bristol-Myers Squibb
BMY
+$8.43M
5
ADBE icon
Adobe
ADBE
+$8.31M

Sector Composition

Rank Sector Weight
1 Technology 15.67%
2 Healthcare 15.06%
3 Consumer Discretionary 13.46%
4 Industrials 11.68%
5 Financials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADXS
2126
DELISTED
Advaxis Inc
ADXS
-30
Closed -$6K
INOV
2127
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-31,443
Closed -$950K
FLXN
2128
DELISTED
Flexion Therapeutics, Inc.
FLXN
-9,207
Closed -$207K
LORL
2129
DELISTED
Loral Space and Communications, Inc.
LORL
-3,734
Closed -$256K
EBSB
2130
DELISTED
Meridian Bancorp, Inc.
EBSB
-14,647
Closed -$193K
RPAI
2131
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
-12,700
Closed -$204K
TLGT
2132
DELISTED
Teligent, Inc
TLGT
-5,670
Closed -$463K
GPX
2133
DELISTED
GP Strategies Corp.
GPX
-6,401
Closed -$237K
WRI
2134
DELISTED
Weingarten Realty Investors
WRI
-10,295
Closed -$370K
ALXN
2135
DELISTED
Alexion Pharmaceuticals
ALXN
-11,810
Closed -$2.05M
NAV
2136
DELISTED
Navistar International
NAV
-6,681
Closed -$197K
BPFH
2137
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-21,500
Closed -$261K
CATM
2138
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
-1,125
Closed -$42K
CMD
2139
DELISTED
Cantel Medical Corporation
CMD
-6,779
Closed -$322K
CUB
2140
DELISTED
Cubic Corporation
CUB
-6,059
Closed -$314K
FLIR
2141
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
-9,208
Closed -$288K
WDR
2142
DELISTED
Waddell & Reed Financial, Inc.
WDR
-5,660
Closed -$280K
HMSY
2143
DELISTED
HMS Holdings Corp.
HMSY
-73,408
Closed -$1.13M
GEN
2144
DELISTED
Genesis Healthcare, Inc.
GEN
-41,326
Closed -$294K
CEL
2145
DELISTED
Cellcom Israel, Ltd.
CEL
-11,126
Closed -$53K
NGHC
2146
DELISTED
National General Holdings Corp
NGHC
-11,274
Closed -$211K
DNKN
2147
DELISTED
Dunkin' Brands Group, Inc.
DNKN
-6,301
Closed -$300K
ONDK
2148
DELISTED
On Deck Capital, Inc.
ONDK
-15,226
Closed -$324K
CCMP
2149
DELISTED
CMC Materials, Inc. Common Stock
CCMP
-8,577
Closed -$429K
ENT
2150
DELISTED
Global Eagle Entertainment Inc.
ENT
-360
Closed -$120K

Similar funds

Cubist Systematic Strategies's Q2 2015 Portfolio in Review

As of Q2 2015, Cubist Systematic Strategies held 2,312 positions worth $2.05B, up 0.2% from $2.04B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Cubist Systematic Strategies's Q2 2015 filing shows 444 new, 666 increased, 682 reduced and 516 closed positions. Its largest new stake was Ultimate Software Group Inc: 29,148 shares worth $4.79M. The largest sale was Gilead Sciences, an estimated $10.7M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Cubist Systematic Strategies's largest Q2 2015 buy was Ultimate Software Group Inc: 29,148 shares worth $4.79M.
  • Cubist Systematic Strategies added most to Hilton Worldwide in Q2 2015, an estimated $17.5M increase.
  • Cubist Systematic Strategies's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $10.7M.
  • Cubist Systematic Strategies fully exited RTX Corp in Q2 2015, selling an estimated $7.16M.
  • Cubist Systematic Strategies's ten largest holdings make up 6.8% of its $2.05B portfolio in Q2 2015.
  • Cubist Systematic Strategies opened 444 new positions and closed 516 in Q2 2015.
  • Cubist Systematic Strategies's portfolio value rose 0.2% quarter-over-quarter to $2.05B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2015, filed 14 Aug 2015.